HROWM Projected Dividend Yield
Sr Nt/Harrow Inc ( NASDAQ : HROWM )Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures. 12 YEAR PERFORMANCE RESULTS |
HROWM Dividend History Detail HROWM Dividend News HROWM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2025 |
Apr 02, 2025 |
Apr 15, 2025 |
Apr 15, 2025 |
Apr 30, 2025 |
0.7422 |
2025 |
Jan 07, 2025 |
Jan 15, 2025 |
Jan 15, 2025 |
Jan 31, 2025 |
0.7422 |
2025 Total: |
1.4844 |
||||
2024 |
Oct 04, 2024 |
Oct 15, 2024 |
Oct 15, 2024 |
Oct 31, 2024 |
0.7422 |
2024 |
Jul 02, 2024 |
Jul 15, 2024 |
Jul 15, 2024 |
Jul 31, 2024 |
0.7422 |
2024 |
Apr 03, 2024 |
Apr 12, 2024 |
Apr 15, 2024 |
Apr 30, 2024 |
0.7422 |
2024 |
Jan 03, 2024 |
Jan 11, 2024 |
Jan 15, 2024 |
Jan 31, 2024 |
0.7422 |
2024 Total: |
2.9688 |
||||
2023 |
Oct 06, 2023 |
Oct 12, 2023 |
Oct 15, 2023 |
Oct 31, 2023 |
0.7422 |
2023 |
Jul 05, 2023 |
Jul 13, 2023 |
Jul 15, 2023 |
Jul 31, 2023 |
0.7422 |
2023 |
Apr 04, 2023 |
Apr 13, 2023 |
Apr 15, 2023 |
Apr 30, 2023 |
0.7422 |
2023 |
Jan 06, 2023 |
Jan 12, 2023 |
Jan 15, 2023 |
Jan 31, 2023 |
0.3381 |
2023 Total: |
2.5647 |